NCLT approves scheme of amalgamation of Biocon Research with Biocon Biologics

Image
Capital Market
Last Updated : Feb 08 2020 | 11:05 AM IST
Biocon announced that the National Company Law Tribunal, Bengaluru Bench, has sanctioned the scheme of amalgamation of Biocon Research (transferor company) with Biocon Biologics (transferee company) and their respectively shareholders. The transferor and transferee company both are subsidiaries of Biocon.

The Certified Copy of this Order sanctioning the Scheme has been filed with the Registrar of Companies (ROC), Bengaluru, Karnataka on 07 February 2020.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 08 2020 | 10:53 AM IST

Next Story